Enlivex announced the launch of OpenClaw, an AI‑ready interface that lets developers create prediction markets with a single prompt, and a $5 million grant program to support builders worldwide in launching and monetizing their own prediction‑market platforms on the Rain protocol.
The interface lowers the technical barrier for market creation, which is expected to increase adoption of the Rain protocol and boost trading volume. Higher volume feeds the protocol’s 2.5 % buy‑and‑burn mechanism, reducing RAIN token supply and potentially raising its value—an outcome that directly supports Enlivex’s treasury strategy.
Enlivex’s dual‑engine business model combines clinical development of Allocetra with a treasury strategy that relies on the Rain protocol. The new initiative strengthens the treasury engine and complements the company’s recent FDA IND clearance for a Phase 2b trial of Allocetra for knee osteoarthritis, providing a diversified revenue path.
CEO Oren Hershkovitz said: "As a major holder of RAIN in our treasury portfolio, we are pleased with the milestones that the Rain Foundation is accomplishing. Allowing anyone using OpenClaw or other AI agents to generate a live prediction market via a single prompt to the agent is a forward‑looking business concept, and we believe this presents the opportunity for the Rain protocol to increase its position as a leading decentralized prediction markets platform."
The Rain protocol’s token economics, which include a 2.5 % buy‑and‑burn mechanism, mean that increased trading volume from the new interface and grant program is likely to support higher token value, thereby enhancing Enlivex’s treasury holdings and overall financial position.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.